Sign in

You're signed outSign in or to get full access.

ALIGN TECHNOLOGY (ALGN)

--

Earnings summaries and quarterly performance for ALIGN TECHNOLOGY.

Research analysts who have asked questions during ALIGN TECHNOLOGY earnings calls.

Elizabeth Anderson

Elizabeth Anderson

Evercore ISI

6 questions for ALGN

Also covers: AGL, CAH, COR +23 more
EW

Erin Wright

Morgan Stanley

6 questions for ALGN

Also covers: BTSG, CAH, CI +18 more
Jason Bednar

Jason Bednar

Piper Sandler Companies

6 questions for ALGN

Also covers: COO, EDAP, GEHC +15 more
Michael Cherny

Michael Cherny

Leerink Partners

6 questions for ALGN

Also covers: ACCD, CAH, CERT +18 more
BV

Brandon Vazquez

William Blair & Company, L.L.C.

5 questions for ALGN

Also covers: CBLL, CVRX, DXCM +17 more
Jonathan Block

Jonathan Block

Stifel Financial Corp.

5 questions for ALGN

Also covers: COO, CUTR, ELAN +11 more
Michael Ryskin

Michael Ryskin

Bank of America Merrill Lynch

5 questions for ALGN

Also covers: A, AVTR, BRKR +28 more
DS

David Saxon

Needham & Company

4 questions for ALGN

Also covers: ALC, ATEC, AZTA +11 more
Jeffrey Johnson

Jeffrey Johnson

Robert W. Baird & Co. Inc.

4 questions for ALGN

Also covers: ALC, BBNX, COO +11 more
Kevin Caliendo

Kevin Caliendo

UBS

4 questions for ALGN

Also covers: AHCO, AMWL, CAH +15 more
Steven Valiquette

Steven Valiquette

Mizuho

3 questions for ALGN

Also covers: CAH, COR, DOCS +12 more
VC

Vik Chopra

Wells Fargo & Company

3 questions for ALGN

Also covers: ATEC, CNMD, ENOV +8 more
DF

Dylan Finley

B. Riley Securities

2 questions for ALGN

Also covers: XRAY, ZIMV
Jeff Johnson

Jeff Johnson

Robert W. Baird & Co.

2 questions for ALGN

Also covers: ALC, COO, HSIC +3 more
MS

Michael Sarcone

Jefferies

2 questions for ALGN

Also covers: ALC, AXGN, CTSO +12 more
SV

Steve Valiquette

Mizuho Financial Group, Inc.

2 questions for ALGN

Also covers: TALK
GS

Glen Santangelo

Jefferies

1 question for ALGN

Also covers: ANIP, BHC, COR +11 more
JB

Jon Block

Stifel, Nicolaus & Company, Incorporated

1 question for ALGN

Also covers: COO, DXCM, ELAN +4 more
Russell Yuen

Russell Yuen

William Blair & Company

1 question for ALGN

Also covers: ENOV, NVST
VC

Vikramjeet Chopra

Wells Fargo & Company

1 question for ALGN

Also covers: ATEC, CNMD, ENOV +9 more

Recent press releases and 8-K filings for ALGN.

Align Technology announces Q4 2025 results
ALGN
Earnings
Guidance Update
Share Buyback
  • Q4 total revenue of $1.048 billion, up 5.3% YoY; full-year 2025 revenue of $4.0 billion, up 1% YoY
  • Q4 clear aligner revenue of $838 million, up 5.5% YoY, on record volume of 677,000 cases, up 7.7% YoY
  • Q4 non-GAAP operating margin of 26.1%, the highest since 2021, and GAAP operating margin of 14.8%
  • Q4 free cash flow of $187.3 million; cash and cash equivalents of $1.095 billion; repurchased 0.7 million shares at an average $142.87 per share in Q4
  • Q1 2026 revenue outlook of $1.01–$1.03 billion (+3%–5% YoY); full-year 2026 revenue growth expected at 3%–4% with non-GAAP operating margin of ~23.7%
16 hours ago
Align Technology reports Q4 2025 results
ALGN
Earnings
Guidance Update
  • Record Q4 revenues of $1.048 billion, up 5.3% year-over-year, and full-year 2025 revenues of $4 billion, up 1% year-over-year
  • Q4 clear aligner revenues of $838 million with record 677,000 cases shipped, up 5.5% in revenue and 7.7% in volume year-over-year
  • Non-GAAP operating margin of 26.1%, the highest since 2021, and non-GAAP gross margin of 72% in Q4
  • Q1 2026 revenue guidance of $1.01 billion–$1.03 billion (up 3–5% YoY) and full-year 2026 revenue growth of 3–4%, with GAAP operating margin expected near 18%
17 hours ago
Align Technology reports Q4 2025 results
ALGN
Earnings
Guidance Update
  • Q4 revenues $1.048 B, +5.3% y/y; FY 2025 revenues $4.0 B, +1% y/y.
  • Q4 clear aligner revenues $838 M, +5.5% y/y; record Q4 volume 677 K cases, +7.7% y/y; FY 2025 volume 2.6 M cases, +4.7% y/y.
  • Q4 non-GAAP operating margin 26.1%, up 230 bps sequentially and highest since 2021; FY 2025 non-GAAP operating margin 22.7%.
  • Q1 2026 revenue guidance $1.01 B–$1.03 B (+3%–5% y/y); FY 2026 revenue growth guidance +3%–4% with non-GAAP operating margin ~23.7%.
17 hours ago
Align Technology announces Q4 2025 and fiscal 2025 results
ALGN
Earnings
Guidance Update
  • Record Q4’25 total revenues of $1,047.6 M (up 5.3% YoY), driven by clear aligner revenues of $838.1 M and 676.9 K aligner cases shipped (up 7.7% YoY).
  • FY2025 total revenues of $4.0 B (up 0.9% YoY), clear aligner revenues of $3.2 B, and 2.6 M aligner cases shipped (up 4.7% YoY).
  • GAAP Q4’25 gross margin of 65.3% (non-GAAP 72.0%); net income of $135.8 M or $1.89 EPS.
  • Q1’26 revenue guidance of $1,010 M–$1,030 M (up 3%–5% YoY) and FY2026 revenue growth of 3%–4%, with mid-single-digit volume growth expected.
19 hours ago
Align Technology reports Q4 and FY 2025 results
ALGN
Earnings
Guidance Update
  • Q4’25 total revenues were $1,047.6 M, up 5.2% QoQ and 5.3% YoY; Clear Aligner revenues were $838.1 M with volumes of 676.9 K cases, rising 4.5% QoQ and 7.7% YoY.
  • Q4’25 GAAP gross margin was 65.3% and operating margin 14.8%; GAAP net income was $135.8 M or $1.89 diluted EPS (non-GAAP: $236.0 M, $3.29 EPS).
  • FY 2025 total revenues reached $4.035 B (+0.9% YoY), with Clear Aligner revenues of $3.245 B (+0.5%) and Systems & Services at $789.6 M (+2.7%).
  • FY 2025 GAAP net income was $410.4 M ($5.65 EPS); non-GAAP net income was $763.0 M ($10.51 EPS).
  • For Q1’26, management expects revenues of $1,010 M–$1,030 M (+3–5% YoY) and Clear Aligner volumes up mid-single digits; full-year 2026 revenue growth is forecast at 3–4%, GAAP operating margin ~18%, non-GAAP ~23.7%.
19 hours ago
Align Technology launches Invisalign® System with mandibular advancement
ALGN
Product Launch
  • Align introduced the Invisalign® System with mandibular advancement featuring occlusal blocks, a clear aligner solution that advances the mandible while straightening teeth to correct Class II skeletal and dental malocclusions.
  • The system is intended for growing patients (ages 10–16) in late mixed or early permanent dentition, using occlusal blocks to leverage natural growth potential for efficient Class II correction.
  • Benefits include streamlined treatment without auxiliary appliances, improved patient comfort and compliance via SmartTrack™ material, and predictable tooth movement through SmartForce™ and SmartStage™ technologies.
  • The product is now commercially available to Invisalign-trained doctors across key Asia Pacific markets, including Australia, New Zealand, Japan, China, and Southeast Asia.
Dec 9, 2025, 2:00 AM
Align Technology outlines product and margin strategy at HealthCONx Conference
ALGN
Product Launch
New Projects/Investments
  • Align Technology will launch the Zero by Three no-refinement, three-year aligner product suite broadly in North America in Q1 2026, followed by phased rollouts in Europe and APEC, offering doctors tiered pricing and the option to purchase refinements at $180 each in the U.S.
  • CFO John Morici expects a 1%–2% ASP headwind in the near term from country and product mix shifts, offset by a targeted 100 bp operating margin improvement in 2026 driven by portfolio evolution and recent restructuring
  • Partnerships with DSOs are delivering double-digit North American growth by emphasizing active patient conversion, digital treatment planning, financing solutions, and leveraging the DSP subscription program for aligners
  • The company plans to initiate direct fabrication in 2026 with printed retainers using proprietary high-viscosity resin on Cubicure printers, progressing to more complex aligner products in 2027 to realize material and labor efficiencies
Dec 3, 2025, 1:20 PM
Align Technology outlines product and manufacturing strategy at HealthCONx conference
ALGN
Product Launch
Guidance Update
  • Zero by Three product suite introduced, offering a 3-year no-refinement aligner option alongside existing 3- and 5-year plans, enhancing customer choice and aligning deferred revenue accounting across products.
  • ASPs projected to decrease 1–2% in the near term due to country and product mix shifts and tiered discounts, while expecting 100 bps gross margin improvement and overall op-margin leverage from product evolution and restructuring.
  • Adoption of an active patient engagement model in the U.S.—including intraoral scanning, treatment simulation, targeted financing under $100/month, and localized marketing—has driven double-digit growth in DSO volume.
  • Align is positioned in China with end-to-end local operations to navigate evolving Value-Based Purchasing policies, viewing potential cost convergence between clear aligners and wires/brackets as an opportunity to expand its 15% aligner share.
  • Direct-fabrication roadmap targets a retainer launch in 2026, using proprietary high-viscosity bio-sourced resin and Cubicure printers, progressing toward mass production of customized aligners with improved material and labor efficiency.
Dec 3, 2025, 1:20 PM
Align Technology details product launches and strategic priorities at HealthCONx Conference
ALGN
Product Launch
  • Align to launch Zero by Three, a no-refinement, three-year aligner product in North America in 1Q26, with Europe and APEC rollouts later in the year; refinements priced at $180 per case in the U.S.
  • ASP expected to decline 1–2% in the near term due to country and product mix, while targeting a 100 bp operating-margin improvement in 2026 through gross-margin gains and cost restructuring
  • U.S. DSO channels experienced double-digit volume growth in 2025, driven by active patient conversion strategies and enhanced doctor support programs
  • Direct-fabrication roadmap uses a bio-sourced, high-viscosity resin and the Cubicure platform, with the first 3D-printed retainer launching in 2026 and scale-up to complex aligners by 2027
Dec 3, 2025, 1:20 PM
Align Technology CFO outlines growth strategy at Piper Sandler Conference
ALGN
Product Launch
New Projects/Investments
  • CFO John Morici noted US consumer demand remains stable, underpinning active conversion efforts through DSOs and targeted marketing to drive Invisalign case volumes.
  • Over 50% of Align’s revenues come from underpenetrated international markets—including India, Southeast Asia and Eastern Europe—which are delivering strong double-digit growth via digital orthodontic adoption and DSO partnerships.
  • In China, with <15% clear aligner penetration versus 85% wires/brackets, anticipated VBP reforms may narrow the price gap and accelerate clear aligner conversions, leveraging Align’s local manufacturing footprint.
  • The company is expanding its portfolio with zero-refinement and tiered service options to give doctors pricing and treatment flexibility, rolling out broadly in North America in Q1 2026.
  • Align’s direct-fabrication scale-up continues: retainers launch mid-2026, followed by more complex appliance production and full aligner manufacturing in 2027.
Dec 2, 2025, 1:00 PM